Türkiye'de İleri Evre Küçük Hücreli Dışı Akciğer Kanserinde Pemetrexed ve Gemcitabine Tedavilerinin Maliyet Etkililik Analizi
Tarih
2013
publications
0
supporting
0
mentioning
0
contrasting
0
Smart Citations0
0
0
0
Citing PublicationsSupportingMentioningContrasting
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Üst veri
Tüm öğe kaydını gösterÖzet
The purpose of the study is to determine the cost effectiveness of the chemotherapy medications that contain gemcitabine and pemetrexed which are used in the first line treatment of advanced non-small cell lung cancer (NSCLC). Within the scope of the study, effectiveness and cost of platinum-based pemetrexed and platinum-based gemcitabine treatments as the first line treatment of advanced NSCLC was evaluated with the use of Markov model and from the perspective of the Social Security Institution. In Markov model, the transitions between the life-long health conditions of advanced NSCLC patients are simulated with the use of cycles of one month.
